Drug information for TENOFOVIR DISOPROXIL FUMARATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 300MG Tentative Approval   TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil CIPLA LIMITED 78800
2009-05-06 Letter
TABLET; ORAL 300MG Tentative Approval   TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil MATRIX LABS 79071
2008-01-09 Letter
TABLET; ORAL 300MG Tentative Approval   TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil INVAGEN PHARMS 90636
2010-04-05 Letter
TABLET; ORAL 300MG Tentative Approval   TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil AUROBINDO PHARMA LTD 90647
2009-02-23 Letter
TABLET; ORAL 300MG Tentative Approval   TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil STRIDES ARCOLAB LTD 90742
2011-05-31 Letter
TABLET; ORAL 300MG Tentative Approval   TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil TEVA PHARMS 91612

Drug Adverse Effects information for TENOFOVIR DISOPROXIL FUMARATE

Role code Indications Reaction # Reports
PS ABDOMINAL PAIN ABORTION SPONTANEOUS 1
PS ANTIRETROVIRAL THERAPY ABORTION SPONTANEOUS 2
PS CONTRACEPTION ABORTION SPONTANEOUS 1
PS CONTRACEPTION DYSFUNCTIONAL UTERINE BLEEDING 1
PS CONTRACEPTION HYPOSPADIAS 1
PS HEPATITIS B ASTHENIA 2
PS HEPATITIS B DEPRESSION 2
PS HEPATITIS B GAIT DISTURBANCE 2
PS HEPATITIS B MUSCULAR WEAKNESS 2
PS HEPATITIS B MUSCULOSKELETAL PAIN 2
PS HEPATITIS B PSORIASIS 2
PS HEPATITIS B RHABDOMYOLYSIS 2
PS HEPATITIS B UPPER GASTROINTESTINAL HAEMORRHAGE 1
PS HEPATITIS B VISUAL IMPAIRMENT 2
PS HEPATITIS B WEIGHT DECREASED 2
PS HIV INFECTION ABORTION SPONTANEOUS 3
PS HIV INFECTION ANAEMIA 1
PS HIV INFECTION APPENDICITIS 1
PS HIV INFECTION COUGH 3
PS HIV INFECTION DEATH 2
PS HIV INFECTION DEEP VEIN THROMBOSIS 3
PS HIV INFECTION DYSFUNCTIONAL UTERINE BLEEDING 1
PS HIV INFECTION DYSPHAGIA 4
PS HIV INFECTION DYSPNOEA 3
PS HIV INFECTION FANCONI SYNDROME ACQUIRED 2
PS HIV INFECTION FEBRILE NEUTROPENIA 6
PS HIV INFECTION FRACTURE 1
PS HIV INFECTION GASTROENTERITIS 1
PS HIV INFECTION HIP FRACTURE 2
PS HIV INFECTION HYPERTENSIVE CRISIS 3
PS HIV INFECTION LEUKOPENIA 6
PS HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 3
PS HIV INFECTION NECROSIS 4
PS HIV INFECTION NEPHROPATHY 2
PS HIV INFECTION NEUTROPENIA 9
PS HIV INFECTION OSTEOPOROSIS 1
PS HIV INFECTION PYREXIA 3
PS HIV INFECTION RENAL FAILURE ACUTE 1
PS HIV INFECTION RENAL TUBULAR DISORDER 1
PS HIV INFECTION SWELLING 4
PS HIV INFECTION TONSILLAR DISORDER 4
PS HIV INFECTION VENTRICULAR SEPTAL DEFECT 9
PS INFECTION PROPHYLAXIS DEAFNESS UNILATERAL 2
PS INFECTION PROPHYLAXIS DEEP VEIN THROMBOSIS 1
PS MALAISE ABORTION SPONTANEOUS 1
PS MALARIA ABORTION SPONTANEOUS 1
PS OSTEOPOROSIS FANCONI SYNDROME ACQUIRED 5
PS OSTEOPOROSIS HIP FRACTURE 5
PS PEPTIC ULCER ABORTION SPONTANEOUS 1
PS PRODUCT USED FOR UNKNOWN INDICATION ABORTION SPONTANEOUS 4
PS PROPHYLAXIS ABDOMINAL PAIN LOWER 1
PS PROPHYLAXIS ACUTE HIV INFECTION 1
PS PROPHYLAXIS ACUTE PRERENAL FAILURE 1
PS PROPHYLAXIS DEAFNESS UNILATERAL 1
PS PROPHYLAXIS DECREASED APPETITE 1
PS PROPHYLAXIS DEHYDRATION 1
PS PROPHYLAXIS GASTROENTERITIS 1
PS PROPHYLAXIS HAEMOGLOBIN DECREASED 1
PS PROPHYLAXIS HYPOAESTHESIA 1
PS PROPHYLAXIS HYPOPHAGIA 1
PS PROPHYLAXIS HYPOTENSION 1
PS PROPHYLAXIS ORTHOSTATIC HYPOTENSION 1
PS PROPHYLAXIS PALPITATIONS 1
PS PROPHYLAXIS PARAESTHESIA 1
PS PROPHYLAXIS PROSTATIC CYST 1
PS PROPHYLAXIS PROSTATOMEGALY 1
PS PROPHYLAXIS AGAINST HIV INFECTION ABORTION SPONTANEOUS 4
PS PROPHYLAXIS AGAINST HIV INFECTION ABORTION SPONTANEOUS COMPLETE 2
PS PROPHYLAXIS AGAINST HIV INFECTION INGUINAL HERNIA 1
PS PROPHYLAXIS AGAINST HIV INFECTION MALARIA 2
PS PROPHYLAXIS AGAINST HIV INFECTION PEPTIC ULCER 1
PS PROPHYLAXIS AGAINST HIV INFECTION PNEUMONIA 1
PS TUBERCULOSIS COUGH 4
PS TUBERCULOSIS DEEP VEIN THROMBOSIS 2
PS TUBERCULOSIS DYSPNOEA 4
PS TUBERCULOSIS HYPERTENSIVE CRISIS 1
PS TUBERCULOSIS NEUTROPENIA 1
PS TUBERCULOSIS PYREXIA 4
PS URINARY TRACT INFECTION ABORTION SPONTANEOUS 1
SS ACQUIRED IMMUNODEFICIENCY SYNDROME ADRENAL INSUFFICIENCY 4
SS ACQUIRED IMMUNODEFICIENCY SYNDROME CUSHING'S SYNDROME 4
SS ACQUIRED IMMUNODEFICIENCY SYNDROME HAIR GROWTH ABNORMAL 4
SS ACQUIRED IMMUNODEFICIENCY SYNDROME IATROGENIC INJURY 4
SS ACQUIRED IMMUNODEFICIENCY SYNDROME RASH 4
SS ACQUIRED IMMUNODEFICIENCY SYNDROME WEIGHT INCREASED 4
SS ANTIRETROVIRAL THERAPY ABORTION SPONTANEOUS 11
SS ANTIRETROVIRAL THERAPY BLOOD HIV RNA INCREASED 3
SS ANTIRETROVIRAL THERAPY CACHEXIA 8
SS ANTIRETROVIRAL THERAPY CD4 LYMPHOCYTES DECREASED 3
SS ANTIRETROVIRAL THERAPY CENTRAL NERVOUS SYSTEM NECROSIS 3
SS ANTIRETROVIRAL THERAPY CEREBELLAR SYNDROME 3
SS ANTIRETROVIRAL THERAPY CHRONIC FATIGUE SYNDROME 8
SS ANTIRETROVIRAL THERAPY COUGH 3
SS ANTIRETROVIRAL THERAPY DEPRESSION 8
SS ANTIRETROVIRAL THERAPY DRUG RESISTANCE 15
SS ANTIRETROVIRAL THERAPY DYSLIPIDAEMIA 9
SS ANTIRETROVIRAL THERAPY DYSTHYMIC DISORDER 3
SS ANTIRETROVIRAL THERAPY ENCEPHALITIS 3
SS ANTIRETROVIRAL THERAPY FACIAL WASTING 8
SS ANTIRETROVIRAL THERAPY GENERALISED OEDEMA 9
SS ANTIRETROVIRAL THERAPY GRANULOMA 3
SS ANTIRETROVIRAL THERAPY HILAR LYMPHADENOPATHY 3
SS ANTIRETROVIRAL THERAPY HYPOAESTHESIA 8
SS ANTIRETROVIRAL THERAPY HYPONATRAEMIA 3
SS ANTIRETROVIRAL THERAPY IMMUNE RECONSTITUTION SYNDROME 3
SS ANTIRETROVIRAL THERAPY IN VITRO FERTILISATION 9
SS ANTIRETROVIRAL THERAPY LIPODYSTROPHY ACQUIRED 8
SS ANTIRETROVIRAL THERAPY MUSCULAR WEAKNESS 3
SS ANTIRETROVIRAL THERAPY NERVOUS SYSTEM DISORDER 3
SS ANTIRETROVIRAL THERAPY PSYCHIATRIC SYMPTOM 15
SS ANTIRETROVIRAL THERAPY TOXOPLASMOSIS 3
SS ANTIRETROVIRAL THERAPY TREATMENT NONCOMPLIANCE 3
SS ANTIRETROVIRAL THERAPY TUBERCULOSIS 3
SS ANTIRETROVIRAL THERAPY TYPE 2 DIABETES MELLITUS 9
SS ANTIRETROVIRAL THERAPY VASODILATATION 8
SS ANTIVIRAL TREATMENT ASCITES 11
SS ANTIVIRAL TREATMENT CHOLESTASIS 11
SS ANTIVIRAL TREATMENT HAEMATOTOXICITY 11
SS ANTIVIRAL TREATMENT HEPATITIS C 5
SS ANTIVIRAL TREATMENT HYPOPHOSPHATAEMIA 11
SS ANTIVIRAL TREATMENT IRON DEFICIENCY ANAEMIA 11
SS ANTIVIRAL TREATMENT LIPOATROPHY 11
SS ANTIVIRAL TREATMENT LIVER DISORDER 11
SS ANTIVIRAL TREATMENT OESOPHAGEAL VARICES HAEMORRHAGE 11
SS ANTIVIRAL TREATMENT PORTAL HYPERTENSION 11
SS ANTIVIRAL TREATMENT PORTAL VEIN THROMBOSIS 11
SS ANTIVIRAL TREATMENT PROTEINURIA 11
SS ANTIVIRAL TREATMENT SPLENOMEGALY 11
SS ANTIVIRAL TREATMENT TRANSAMINASES INCREASED 11
SS ANTIVIRAL TREATMENT VIROLOGIC FAILURE 11
SS DERMATITIS ADRENAL INSUFFICIENCY 1
SS DERMATITIS ADRENAL SUPPRESSION 1
SS DERMATITIS CUSHING'S SYNDROME 2
SS DERMATITIS HAIR GROWTH ABNORMAL 1
SS DERMATITIS IATROGENIC INJURY 2
SS DERMATITIS RASH 1
SS DERMATITIS WEIGHT INCREASED 1
SS DIFFUSE LARGE B-CELL LYMPHOMA BLOOD TEST ABNORMAL 6
SS DIFFUSE LARGE B-CELL LYMPHOMA FEBRILE NEUTROPENIA 19
SS DIFFUSE LARGE B-CELL LYMPHOMA NEUTROPHIL MORPHOLOGY ABNORMAL 4
SS DIFFUSE LARGE B-CELL LYMPHOMA PANCYTOPENIA 9
SS DIFFUSE LARGE B-CELL LYMPHOMA PYREXIA 4
SS DIFFUSE LARGE B-CELL LYMPHOMA VIRAL INFECTION 6
SS DIFFUSE LARGE B-CELL LYMPHOMA WHITE BLOOD CELL MORPHOLOGY ABNORMAL 4
SS HIV INFECTION ABSCESS NECK 3
SS HIV INFECTION ADRENAL SUPPRESSION 4
SS HIV INFECTION AIDS ENCEPHALOPATHY 12
SS HIV INFECTION ANAEMIA 4
SS HIV INFECTION ARTHRALGIA 6
SS HIV INFECTION ARTHRITIS 6
SS HIV INFECTION ASCITES 4
SS HIV INFECTION ASTHENIA 7
SS HIV INFECTION BLOOD ALKALINE PHOSPHATASE INCREASED 7
SS HIV INFECTION BLOOD CALCIUM DECREASED 7
SS HIV INFECTION BLOOD THYROID STIMULATING HORMONE INCREASED 6
SS HIV INFECTION CENTRAL NERVOUS SYSTEM LESION 12
SS HIV INFECTION COGNITIVE DISORDER 12
SS HIV INFECTION CRYOGLOBULINS PRESENT 6
SS HIV INFECTION CUSHING'S SYNDROME 8
SS HIV INFECTION DEEP VEIN THROMBOSIS 3
SS HIV INFECTION DEMENTIA 4
SS HIV INFECTION DERMATITIS 4
SS HIV INFECTION DIARRHOEA 3
SS HIV INFECTION DIPLOPIA 6
SS HIV INFECTION DRUG INTERACTION 4
SS HIV INFECTION DYSPHAGIA 4
SS HIV INFECTION DYSPHONIA 6
SS HIV INFECTION FEBRILE NEUTROPENIA 6
SS HIV INFECTION GAMMA-GLUTAMYLTRANSFERASE INCREASED 7
SS HIV INFECTION GENERALISED OEDEMA 6
SS HIV INFECTION HEADACHE 12
SS HIV INFECTION HYDROCELE 8
SS HIV INFECTION HYPERTHYROIDISM 6
SS HIV INFECTION HYPOTHYROIDISM 6
SS HIV INFECTION IATROGENIC INJURY 4
SS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 9
SS HIV INFECTION INFLAMMATION 3
SS HIV INFECTION KLEBSIELLA INFECTION 3
SS HIV INFECTION LARGE INTESTINAL HAEMORRHAGE 4
SS HIV INFECTION LETHARGY 6
SS HIV INFECTION LYMPHADENITIS BACTERIAL 3
SS HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 8
SS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 7
SS HIV INFECTION MELAENA 4
SS HIV INFECTION NECROSIS 4
SS HIV INFECTION NEOPLASM MALIGNANT 6
SS HIV INFECTION NEUTROPENIA 3
SS HIV INFECTION NEUTROPHIL MORPHOLOGY ABNORMAL 3
SS HIV INFECTION OSTEOPOROSIS 31
SS HIV INFECTION PANCYTOPENIA 10
SS HIV INFECTION PARAESTHESIA 12
SS HIV INFECTION PORTAL HYPERTENSION 56
SS HIV INFECTION PREGNANCY 4
SS HIV INFECTION PREMATURE SEPARATION OF PLACENTA 3
SS HIV INFECTION PULMONARY ARTERIAL HYPERTENSION 8
SS HIV INFECTION RENAL FAILURE ACUTE 3
SS HIV INFECTION RENAL TUBULAR DISORDER 2
SS HIV INFECTION RHABDOMYOLYSIS 3
SS HIV INFECTION RHEUMATOID ARTHRITIS 6
SS HIV INFECTION RHEUMATOID FACTOR INCREASED 6
SS HIV INFECTION SECONDARY ADRENOCORTICAL INSUFFICIENCY 4
SS HIV INFECTION SKIN ULCER 7
SS HIV INFECTION SQUAMOUS CELL CARCINOMA OF SKIN 6
SS HIV INFECTION STILLBIRTH 3
SS HIV INFECTION SYNOVITIS 6
SS HIV INFECTION TONSILLAR DISORDER 4
SS HIV INFECTION URINARY TRACT INFECTION 7
SS HIV INFECTION VARICES OESOPHAGEAL 4
SS HIV INFECTION VISION BLURRED 12
SS HIV INFECTION WEIGHT INCREASED 6
SS HIV INFECTION WOUND 6
SS MATERNAL EXPOSURE DURING PREGNANCY MATERNAL EXPOSURE DURING PREGNANCY 8
SS MATERNAL EXPOSURE DURING PREGNANCY PREMATURE BABY 4
SS MATERNAL EXPOSURE DURING PREGNANCY VENTRICULAR SEPTAL DEFECT 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED FOETAL EXPOSURE DURING PREGNANCY 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED PREMATURE BABY 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED VENTRICULAR SEPTAL DEFECT 8
SS PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 1
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 1
SS PRODUCT USED FOR UNKNOWN INDICATION RHABDOMYOLYSIS 1
SS TUBERCULOSIS DEEP VEIN THROMBOSIS 1
SS URINARY TRACT INFECTION ABORTION SPONTANEOUS 1
C ABNORMAL BEHAVIOUR ALCOHOL ABUSE 1
C ABNORMAL BEHAVIOUR BLOOD POTASSIUM INCREASED 1
C ABNORMAL BEHAVIOUR DRUG INTERACTION 1
C ABNORMAL BEHAVIOUR DRUG LEVEL INCREASED 1
C ABNORMAL BEHAVIOUR ELECTROCARDIOGRAM QT PROLONGED 1
C ABNORMAL BEHAVIOUR SEDATION 1
C ACUTE LEUKAEMIA VENTRICULAR FIBRILLATION 6
C ANAEMIA INTRACRANIAL PRESSURE INCREASED 1
C ANAEMIA MENINGITIS CRYPTOCOCCAL 2
C ANAEMIA TREATMENT FAILURE 2
C ANTIBIOTIC PROPHYLAXIS RENAL FAILURE 2
C ANTIFUNGAL PROPHYLAXIS RENAL FAILURE 1
C ANTIRETROVIRAL THERAPY BACTERIAL SEPSIS 4
C ANTIRETROVIRAL THERAPY NEUTROPENIA 4
C ANTIVIRAL PROPHYLAXIS BURKITT'S LYMPHOMA 3
C ANTIVIRAL PROPHYLAXIS CEREBRAL TOXOPLASMOSIS 3
C ANTIVIRAL PROPHYLAXIS NEOPLASM RECURRENCE 3
C ANTIVIRAL PROPHYLAXIS OFF LABEL USE 3
C ANTIVIRAL PROPHYLAXIS URINARY RETENTION 3
C ANXIETY CLOSTRIDIAL INFECTION 1
C ANXIETY ENTEROCOLITIS 1
C ANXIETY NAUSEA 1
C ANXIETY NEOPLASM MALIGNANT 1
C ANXIETY PAIN 1
C ANXIETY VOMITING 1
C ASTHMA ASTHMA 8
C ASTHMA CUSHING'S SYNDROME 8
C BLOOD CHOLESTEROL INCREASED FIBROSIS 1
C BLOOD CHOLESTEROL INCREASED MACULAR OEDEMA 1
C BLOOD CHOLESTEROL INCREASED NAUSEA 1
C BLOOD CHOLESTEROL INCREASED VISUAL ACUITY REDUCED 1
C BURKITT'S LYMPHOMA BURKITT'S LYMPHOMA 11
C BURKITT'S LYMPHOMA CEREBRAL TOXOPLASMOSIS 11
C BURKITT'S LYMPHOMA NEOPLASM RECURRENCE 11
C BURKITT'S LYMPHOMA OFF LABEL USE 11
C BURKITT'S LYMPHOMA URINARY RETENTION 11
C CARDIOVASCULAR EVENT PROPHYLAXIS FIBROSIS 1
C CARDIOVASCULAR EVENT PROPHYLAXIS MACULAR OEDEMA 1
C CARDIOVASCULAR EVENT PROPHYLAXIS NAUSEA 1
C CARDIOVASCULAR EVENT PROPHYLAXIS VISUAL ACUITY REDUCED 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS CONJUNCTIVITIS 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS INFLAMMATION 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS RASH 1
C CONVULSION CLOSTRIDIAL INFECTION 1
C CONVULSION ENTEROCOLITIS 1
C CONVULSION INTRACRANIAL PRESSURE INCREASED 1
C CONVULSION MENINGITIS CRYPTOCOCCAL 2
C CONVULSION NAUSEA 1
C CONVULSION NEOPLASM MALIGNANT 1
C CONVULSION PAIN 1
C CONVULSION TREATMENT FAILURE 2
C CONVULSION VOMITING 1
C DEPRESSION CONJUNCTIVITIS 2
C DEPRESSION INFLAMMATION 2
C DEPRESSION RASH 2
C DIABETES MELLITUS FIBROSIS 1
C DIABETES MELLITUS MACULAR OEDEMA 1
C DIABETES MELLITUS NAUSEA 1
C DIABETES MELLITUS VISUAL ACUITY REDUCED 1
C DRUG DEPENDENCE ALCOHOL ABUSE 1
C DRUG DEPENDENCE BLOOD POTASSIUM INCREASED 1
C DRUG DEPENDENCE DRUG INTERACTION 1
C DRUG DEPENDENCE DRUG LEVEL INCREASED 1
C DRUG DEPENDENCE ELECTROCARDIOGRAM QT PROLONGED 1
C DRUG DEPENDENCE SEDATION 1
C FEBRILE NEUTROPENIA BACTERIAL SEPSIS 6
C FEBRILE NEUTROPENIA NEUTROPENIA 6
C FLUID RETENTION VENTRICULAR FIBRILLATION 2
C GASTROOESOPHAGEAL REFLUX DISEASE FIBROSIS 1
C GASTROOESOPHAGEAL REFLUX DISEASE MACULAR OEDEMA 1
C GASTROOESOPHAGEAL REFLUX DISEASE NAUSEA 1
C GASTROOESOPHAGEAL REFLUX DISEASE VISUAL ACUITY REDUCED 1
C HEADACHE INTRACRANIAL PRESSURE INCREASED 1
C HEADACHE MENINGITIS CRYPTOCOCCAL 2
C HEADACHE TREATMENT FAILURE 2
C HEPATITIS B FIBROSIS 1
C HEPATITIS B MACULAR OEDEMA 1
C HEPATITIS B NAUSEA 1
C HEPATITIS B VENTRICULAR FIBRILLATION 2
C HEPATITIS B VISUAL ACUITY REDUCED 1
C HEPATITIS C VENTRICULAR FIBRILLATION 2
C HIV INFECTION ACIDOSIS 3
C HIV INFECTION ALCOHOL ABUSE 2
C HIV INFECTION ASTHMA 16
C HIV INFECTION BLOOD CREATININE INCREASED 14
C HIV INFECTION BLOOD POTASSIUM INCREASED 2
C HIV INFECTION BONE NEOPLASM MALIGNANT 2
C HIV INFECTION CIRCULATORY COLLAPSE 9
C HIV INFECTION COMA 9
C HIV INFECTION CONGENITAL ANOMALY 1
C HIV INFECTION CONJUNCTIVITIS 3
C HIV INFECTION CUSHING'S SYNDROME 16
C HIV INFECTION DECREASED APPETITE 1
C HIV INFECTION DISTRIBUTIVE SHOCK 3
C HIV INFECTION DRUG INTERACTION 16
C HIV INFECTION DRUG LEVEL INCREASED 16
C HIV INFECTION ELECTROCARDIOGRAM QT PROLONGED 2
C HIV INFECTION FEBRILE NEUTROPENIA 13
C HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 1
C HIV INFECTION GENERALISED OEDEMA 1
C HIV INFECTION HEART RATE INCREASED 3
C HIV INFECTION INFLAMMATION 3
C HIV INFECTION INTRACRANIAL PRESSURE INCREASED 3
C HIV INFECTION LEUKOPENIA 1
C HIV INFECTION MENINGITIS CRYPTOCOCCAL 6
C HIV INFECTION METABOLIC ACIDOSIS 6
C HIV INFECTION OVERDOSE 9
C HIV INFECTION POLYDACTYLY 1
C HIV INFECTION POLYURIA 3
C HIV INFECTION RASH 3
C HIV INFECTION RASH GENERALISED 12
C HIV INFECTION RENAL FAILURE 10
C HIV INFECTION RENAL IMPAIRMENT 14
C HIV INFECTION SEDATION 2
C HIV INFECTION SHOCK 6
C HIV INFECTION TREATMENT FAILURE 6
C HYPERLIPIDAEMIA BLOOD CREATININE INCREASED 1
C HYPERLIPIDAEMIA PROTEINURIA 1
C HYPERLIPIDAEMIA TENDON RUPTURE 1
C HYPERTENSION BLOOD CREATININE INCREASED 6
C HYPERTENSION DRUG INTERACTION 6
C HYPERTENSION DRUG LEVEL INCREASED 6
C HYPERTENSION INTRACRANIAL PRESSURE INCREASED 1
C HYPERTENSION MENINGITIS CRYPTOCOCCAL 2
C HYPERTENSION RENAL IMPAIRMENT 6
C HYPERTENSION TREATMENT FAILURE 2
C LIPIDS INCREASED BLOOD CREATININE INCREASED 2
C LIPIDS INCREASED DRUG INTERACTION 2
C LIPIDS INCREASED DRUG LEVEL INCREASED 2
C LIPIDS INCREASED RENAL IMPAIRMENT 2
C MALIGNANT MELANOMA CLOSTRIDIAL INFECTION 1
C MALIGNANT MELANOMA ENTEROCOLITIS 1
C MALIGNANT MELANOMA NAUSEA 1
C MALIGNANT MELANOMA NEOPLASM MALIGNANT 1
C MALIGNANT MELANOMA PAIN 1
C MALIGNANT MELANOMA VOMITING 1
C MEAN ARTERIAL PRESSURE CIRCULATORY COLLAPSE 5
C MEAN ARTERIAL PRESSURE COMA 5
C MEAN ARTERIAL PRESSURE DISTRIBUTIVE SHOCK 5
C MEAN ARTERIAL PRESSURE METABOLIC ACIDOSIS 5
C MEAN ARTERIAL PRESSURE OVERDOSE 5
C MEAN ARTERIAL PRESSURE RENAL FAILURE 5
C MENINGITIS CRYPTOCOCCAL INTRACRANIAL PRESSURE INCREASED 1
C MENINGITIS CRYPTOCOCCAL MENINGITIS CRYPTOCOCCAL 2
C MENINGITIS CRYPTOCOCCAL TREATMENT FAILURE 2
C MENTAL DISORDER ALCOHOL ABUSE 1
C MENTAL DISORDER BLOOD POTASSIUM INCREASED 1
C MENTAL DISORDER DRUG INTERACTION 1
C MENTAL DISORDER DRUG LEVEL INCREASED 1
C MENTAL DISORDER ELECTROCARDIOGRAM QT PROLONGED 1
C MENTAL DISORDER SEDATION 1
C MIGRAINE BLOOD CREATININE INCREASED 4
C MIGRAINE DRUG INTERACTION 4
C MIGRAINE DRUG LEVEL INCREASED 4
C MIGRAINE RENAL IMPAIRMENT 4
C NAUSEA CLOSTRIDIAL INFECTION 2
C NAUSEA ENTEROCOLITIS 2
C NAUSEA NAUSEA 2
C NAUSEA NEOPLASM MALIGNANT 2
C NAUSEA PAIN 2
C NAUSEA VOMITING 2
C NON-HODGKIN'S LYMPHOMA STAGE IV BACTERIAL SEPSIS 9
C NON-HODGKIN'S LYMPHOMA STAGE IV NEUTROPENIA 9
C OEDEMA VENTRICULAR FIBRILLATION 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS INTRACRANIAL PRESSURE INCREASED 2
C OPPORTUNISTIC INFECTION PROPHYLAXIS MENINGITIS CRYPTOCOCCAL 4
C OPPORTUNISTIC INFECTION PROPHYLAXIS TREATMENT FAILURE 4
C OVERDOSE ACIDOSIS 1
C OVERDOSE CIRCULATORY COLLAPSE 1
C OVERDOSE COMA 1
C OVERDOSE OVERDOSE 1
C OVERDOSE RENAL FAILURE 1
C OVERDOSE SHOCK 1
C PAIN CLOSTRIDIAL INFECTION 1
C PAIN ENTEROCOLITIS 1
C PAIN NAUSEA 1
C PAIN NEOPLASM MALIGNANT 1
C PAIN PAIN 1
C PAIN VOMITING 1
C PRODUCT USED FOR UNKNOWN INDICATION ALCOHOL ABUSE 6
C PRODUCT USED FOR UNKNOWN INDICATION BACTERIAL SEPSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD ALCOHOL INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD CREATININE INCREASED 4
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD POTASSIUM INCREASED 6
C PRODUCT USED FOR UNKNOWN INDICATION CIRCULATORY COLLAPSE 5
C PRODUCT USED FOR UNKNOWN INDICATION COMA 5
C PRODUCT USED FOR UNKNOWN INDICATION DECREASED APPETITE 2
C PRODUCT USED FOR UNKNOWN INDICATION DISTRIBUTIVE SHOCK 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 10
C PRODUCT USED FOR UNKNOWN INDICATION DRUG LEVEL INCREASED 10
C PRODUCT USED FOR UNKNOWN INDICATION ELECTROCARDIOGRAM QT PROLONGED 6
C PRODUCT USED FOR UNKNOWN INDICATION GENERALISED OEDEMA 2
C PRODUCT USED FOR UNKNOWN INDICATION HEART RATE INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION METABOLIC ACIDOSIS 5
C PRODUCT USED FOR UNKNOWN INDICATION NEUTROPENIA 1
C PRODUCT USED FOR UNKNOWN INDICATION OVERDOSE 3
C PRODUCT USED FOR UNKNOWN INDICATION POLYURIA 4
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE 7
C PRODUCT USED FOR UNKNOWN INDICATION RENAL IMPAIRMENT 4
C PRODUCT USED FOR UNKNOWN INDICATION SEDATION 6
C PRODUCT USED FOR UNKNOWN INDICATION SHOCK 4
C PROPHYLAXIS CLOSTRIDIAL INFECTION 1
C PROPHYLAXIS DEPRESSED LEVEL OF CONSCIOUSNESS 1
C PROPHYLAXIS DRUG INTERACTION 1
C PROPHYLAXIS ENTEROCOLITIS 1
C PROPHYLAXIS IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1
C PROPHYLAXIS MEMORY IMPAIRMENT 1
C PROPHYLAXIS NAUSEA 1
C PROPHYLAXIS NEOPLASM MALIGNANT 1
C PROPHYLAXIS PAIN 1
C PROPHYLAXIS RENAL FAILURE 1
C PROPHYLAXIS SOMNOLENCE 1
C PROPHYLAXIS VOMITING 1
C RENAL TRANSPLANT DEPRESSED LEVEL OF CONSCIOUSNESS 3
C RENAL TRANSPLANT DRUG INTERACTION 3
C RENAL TRANSPLANT IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3
C RENAL TRANSPLANT MEMORY IMPAIRMENT 3
C RENAL TRANSPLANT RENAL FAILURE 3
C RENAL TRANSPLANT SOMNOLENCE 3
C SCHIZOAFFECTIVE DISORDER ALCOHOL ABUSE 2
C SCHIZOAFFECTIVE DISORDER BLOOD POTASSIUM INCREASED 2
C SCHIZOAFFECTIVE DISORDER DRUG INTERACTION 2
C SCHIZOAFFECTIVE DISORDER DRUG LEVEL INCREASED 2
C SCHIZOAFFECTIVE DISORDER ELECTROCARDIOGRAM QT PROLONGED 2
C SCHIZOAFFECTIVE DISORDER SEDATION 2
C SUPPLEMENTATION THERAPY INTRACRANIAL PRESSURE INCREASED 2
C SUPPLEMENTATION THERAPY MENINGITIS CRYPTOCOCCAL 4
C SUPPLEMENTATION THERAPY TREATMENT FAILURE 4
C VITAMIN SUPPLEMENTATION RENAL FAILURE 1
C VOMITING CLOSTRIDIAL INFECTION 1
C VOMITING ENTEROCOLITIS 1
C VOMITING NAUSEA 1
C VOMITING NEOPLASM MALIGNANT 1
C VOMITING PAIN 1
C VOMITING VOMITING 1
Ads by Google